Chemspec Europe News
Oxygen shortage slows down Indian chemical industry
08. Juni 2021
India’s ongoing second wave of COVID-19 infections has had a severe knock-on effect on its chemicals and related industries. As of 25 April, the Government has ordered that liquid oxygen can only be supplied for medical use and multiple chemicals producers have halted production of certain items because they are unable to source industrial oxygen.
Multiple battery advances for Johnson Matthey
01. Juni 2021
Within the last six weeks, Johnson Matthey (JM) has opened its new Battery Technology Centre in Oxford, UK, while announcing a new commitment to fully carbon-neutral production of its eLNO nickel-rich advanced cathode materials technology by 2030 and for the whole company by 2040. It has also signed three agreements to secure the supply chain for these materials, and another in the recycling of key raw materials.
BASF, RWE in renewable energy deal
24. Mai 2021
BASF has agreed a deal with German energy giant RWE to source renewable electricity to make ‘green’ hydrogen production at its main site in Ludwigshafen. This will come from a 2-gigawatt offshore wind farm that already has at the planning stage. When complete, it will save 2.8 million tonnes/year of CO2 emissions at the site.
Three CDMOs in HPAPI advances
18. Mai 2021
Sterling Pharma Solutions, Novasep and Fareva have all made announcements in the high potency arena in the past week. Sterling has signed a manufacturing deal with oncology specialist OncoTex, while Novasep is expanding its main high potency API (HPAPI) site in France and Fareva has acquired a high potency drug product facility.
Croda plans strategic review of chemicals
12. Mai 2021
Croda International has announced a strategic review of its Performance Technologies and Industrial Chemicals (PTIC) businesses during the course of this year, with a view to deciding on the best ownership structure for them in the longer term. Full or partial divestment or a spin-off are all options.
Pharma CDMOs in multiple deals
04. Mai 2021
Lonza its to expand its two-year collaboration with Moderna to manufacture the drug substance for Moderna’ COVID-19 vaccine. It will install three additional manufacturing lines at Visp, Switzerland, alongside three existing ones.
Possible action for 290 chemicals
26. April 2021
The European Chemicals Agency (ECHA) has issued its third report on its Integrated Regulatory Strategy. The conclusion was that 290 of the 1,900 registered chemicals the agency assessed last year “may be candidates for further regulatory risk management at EU level if their hazards are confirmed”. More data needs to be generated before any actions can be taken.
Clariant furthers China agenda
13. April 2021
Clariant has further expanded on several fronts in China in the past month, with the official opening of its One Clariant Campus in Shanghai followed swiftly by a new stabiliser facility in Cangzhou in the northern province of Hebei. China accounted for 10% of corporate sales from continuing operation in 2020, at CHF 402 million, and plans are for this to grow further.